Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Efegatran")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 13 of 13

  • Page / 1
Export

Selection :

  • and

Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' dataLancet (British edition). 2002, Vol 359, Num 9303, pp 294-302, issn 0140-6736Article

Research on synthetic peptides of pharmaceutical interest at IDRBAJUSZ, S.Pharmazie. 2001, Vol 56, pp S4-S11, issn 0031-7144, SUP1Conference Paper

Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarctionFUNG, A. Y; LORCH, G; SCHERER, J et al.The American heart journal. 1999, Vol 138, Num 4, pp 696-704, issn 0002-8703, 1Article

Parenteral direct antithrombinsLAUER, M. A; LINCOFF, A. M.Handbook of experimental pharmacology. 1999, Vol 132, pp 331-352, issn 0171-2004Article

Effect of some new thioglycosides on endotoxin-induced disseminated intravascular coagulation in rabbitsSZABO, Gabriella; BARABAS, Eva; KEDVES, Rita et al.Thrombosis research. 2002, Vol 107, Num 6, pp 357-363, issn 0049-3848, 7 p.Article

Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable anginaKLOOTWIJK, P; LENDERINK, T; SIMOONS, M. L et al.European heart journal. 1999, Vol 20, Num 15, pp 1101-1111, issn 0195-668XArticle

Oral thrombin inhibitors : Challenges and progressKIMBALL, S. D.Handbook of experimental pharmacology. 1999, Vol 132, pp 367-396, issn 0171-2004Article

Antithrombotic assessment of the effects of combination therapy with the anticoagulants efegatran and heparin and the glycoprotein IIb-IIIa platelet receptor antagonist 7E3 in a canine model of coronary artery thrombosisSHETLER, T. J; CROWE, V. G; BAILEY, B. D et al.Circulation (New York, N.Y.). 1996, Vol 94, Num 7, pp 1719-1725, issn 0009-7322Article

Management of patients with acute coronary syndromes: What is the clinical role of direct thrombin inhibitors?EIKELBOOM, John W; FRENCH, John.Drugs (Basel). 2002, Vol 62, Num 13, pp 1839-1852, issn 0012-6667, 14 p.Article

Conjunctive therapy to reduce the occurrence of coronary reocclusion after thrombolytic treatment of AMIHAYES, R; GALLO, R; FUSTER, V et al.Handbook of experimental pharmacology. 2001, Vol 146, pp 287-322, issn 0171-2004Article

The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosisELG, M; GUSTAFSSON, D; DEINUM, J et al.Thrombosis and haemostasis. 1997, Vol 78, Num 4, pp 1286-1292, issn 0340-6245Article

Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction: The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trialThe American heart journal. 2002, Vol 143, Num 1, pp 95-105, issn 0002-8703Article

A family of arginal thrombin inhibitors related to efegatranSMITH, G. F; SHUMAN, R. T; ROBERTS, E et al.Seminars in thrombosis and hemostasis. 1996, Vol 22, Num 2, pp 173-183, issn 0094-6176Conference Paper

  • Page / 1